Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Exe VP, Global Commercial Ops | April 28, 2010 | April 30, 2010 |
| Fresh Tracks Therapeutics, Inc.VICL · Entity 90076 | Director | May 23, 2018 | May 24, 2018 |
| NEUROCRINE BIOSCIENCES INCNBIX · Entity 2655 | Director | May 27, 2026 | May 29, 2026 |
| OTONOMY, INC.OTIC · Entity 116495 | Director | June 20, 2017 | July 14, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date April 28, 2010 · Filed April 30, 2010
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 131,889 |
Reported balance
After 2010-04-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2010-04-28 · Tax withholding · Disposed 1,401 · Balance 131,889 |
| Common StockSEC Table I · non-derivative | Direct | 130,488 |
Reported balance
After 2010-04-29 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2010-04-29 · Tax withholding · Disposed 1,401 · Balance 130,488 F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/29/2011; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/28/2011; and 12,000 RSUs which vest in four equal installments of 3,000 each commencing 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 2,717.7088 |
Reported balance
Holding disclosure · report date 2010-04-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,717.7088 F2: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of the date of this filing. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/29/2011; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/28/2011; and 12,000 RSUs which vest in four equal installments of 3,000 each commencing 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of the date of this filing.
Fresh Tracks Therapeutics, Inc.
Report date May 23, 2018 · Filed May 24, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Nonstatutory Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.67 · Expires 2028-05-22 | Direct | 6,500 |
Reported balance
After 2018-05-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-05-23 · Grant · Acquired 6,500 · Balance 6,500 F1: The date in this field is approximate. These options are exercisable at the date of the next annual meeting of stockholders. The date of the meeting has not been set, but is expected to occur in May 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The date in this field is approximate. These options are exercisable at the date of the next annual meeting of stockholders. The date of the meeting has not been set, but is expected to occur in May 2019.
NEUROCRINE BIOSCIENCES INC
Report date May 27, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restriced Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,567 |
Reported balance
After 2026-05-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-27 · Grant · Acquired 2,567 · Balance 2,567 F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2: The RSUs will vest in full on May 27, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
F2: The RSUs will vest in full on May 27, 2027.
OTONOMY, INC.
Report date June 20, 2017 · Filed July 14, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.05 · Expires 2027-06-20 | Direct | 15,000 |
Reported balance
After 2017-06-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-06-20 · Grant · Acquired 15,000 · Balance 15,000 F1: The shares subject to the option vest in full on the date of the Issuer's next annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option vest in full on the date of the Issuer's next annual meeting of stockholders.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ALIGN TECHNOLOGY INC
Report date May 20, 2026 · Filed May 22, 2026
Section 16 reporting ended · disclosed 2026-05-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,036 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Exercise / conversion · Acquired 1,745 · Balance 5,036 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-20 · Exercise / conversion · Disposed 1,745 · Balance 0 F1: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 3,273 |
Reported balance
Holding disclosure · report date 2026-05-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,273 |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 26, 2020 Filed Oct 29, 2020 00:17 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 10,983 | $466.85 | $5,127,434.42 |
DisclosureSEC source: 0001209191-20-056152 · doc4.xml · nonDerivative · entry 3 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,205 F3 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $465.05 to $467.95, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:17 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 4,805 | $464.43 | $2,231,562.61 |
DisclosureSEC source: 0001209191-20-056152 · doc4.xml · nonDerivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,188 F2 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $462.70 to $464.99, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 26, 2020 Filed Oct 29, 2020 00:17 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 1,485 | $460.39 | $683,673.80 |
DisclosureSEC source: 0001209191-20-056152 · doc4.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,993 F1 · price: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $459.725 to $461.31, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 20, 2020 Filed May 21, 2020 22:16 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 1,271 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-031425 · doc4.xml · derivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,271 Underlying: Common Stock · 1,271 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 20, 2020 will become vested on the earlier of (i) May 20, 2021 or (i) the date of the 2021 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 20, 2020 will become vested on the earlier of (i) May 20, 2021 or (i) the date of the 2021 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 19, 2020 Filed May 21, 2020 22:55 UTC | NEUROCRINE BIOSCIENCES INC NBIX · Entity 2655 | GrantNon-Qualified Stock Option · Derivative | 6,018 | $0.00 Strike: $119.93 | $0.00 |
DisclosureSEC source: 0001209191-20-031493 · doc4.xml · derivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,018 Underlying: Common Stock · 6,018 shares Expires 2030-05-19 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 19, 2020. Read SEC document |
| May 15, 2020 Filed May 19, 2020 22:14 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 921 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030661 · doc4.xml · derivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 921 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 15, 2019 became vested on May 15, 2020 and shares were delivered to reporting person on such vest date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 15, 2019 became vested on May 15, 2020 and shares were delivered to reporting person on such vest date. Read SEC document |
| May 15, 2020 Filed May 19, 2020 22:14 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantCommon Stock | 921 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030661 · doc4.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,478 Read SEC document |
| May 22, 2019 Filed May 23, 2019 21:44 UTC | NEUROCRINE BIOSCIENCES INC NBIX · Entity 2655 | GrantNon-Qualified Stock Option · Derivative | 10,000 | $0.00 Strike: $79.79 | $0.00 |
DisclosureSEC source: 0001209191-19-032399 · doc4.xml · derivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-22 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 22, 2019. Read SEC document |
| May 15, 2019 Filed May 18, 2019 01:31 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 921 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000009 · primary_doc.xml · derivative · entry 3 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 921 Underlying: Common Stock · 921 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock F3 · derivative.exercise_date: 100% of the restricted stock unit will become vested on the earlier of (i) May 16, 2020 or (ii) the date of the 2020 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit will become vested on the earlier of (i) May 16, 2020 or (ii) the date of the 2020 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 15, 2019 Filed May 18, 2019 01:31 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 1,042 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000009 · primary_doc.xml · derivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 16, 2018 became vested on May 15, 2019 and shares were delivered to reporting person on that date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 16, 2018 became vested on May 15, 2019 and shares were delivered to reporting person on that date. Read SEC document |
| May 15, 2019 Filed May 18, 2019 01:31 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000009 · primary_doc.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2018 Filed May 25, 2018 23:55 UTC | NEUROCRINE BIOSCIENCES INC NBIX · Entity 2655 | GrantNon-Qualified Stock Option · Derivative | 12,500 | $0.00 Strike: $94.64 | $0.00 |
DisclosureSEC source: 0001209191-18-033627 · doc4.xml · derivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2028-05-24 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 24, 2018. Read SEC document |
| May 23, 2018 Filed May 24, 2018 11:33 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | GrantNonstatutory Stock Option (right to buy) · Derivative | 6,500 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001209191-18-032839 · doc4.xml · derivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock, $.01 par value · 6,500 shares Expires 2028-05-22 F1 · derivative.exercise_date: The date in this field is approximate. These options are exercisable at the date of the next annual meeting of stockholders. The date of the meeting has not been set, but is expected to occur in May 2019. Read SEC document |
| May 16, 2018 Filed May 21, 2018 21:14 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 1,042 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-18-000010 · primary_doc.xml · derivative · entry 3 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,042 Underlying: Common Stock · 1,042 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock F3 · derivative.exercise_date: 100% of the restricted stock unit granted on May 16, 2018 will become vested and exercisable on the earlier of (i) May 16, 2019 or (ii) the date of the 2019 annual meeting of stockholders. Shares will be delivered to reporting person on such vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit granted on May 16, 2018 will become vested and exercisable on the earlier of (i) May 16, 2019 or (ii) the date of the 2019 annual meeting of stockholders. Shares will be delivered to reporting person on such vest date. Read SEC document |
| May 16, 2018 Filed May 21, 2018 21:14 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 3,115 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-18-000010 · primary_doc.xml · derivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,115 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 17, 2017 became vested on May 16, 2018 and shares were delivered to reporting person on such vest date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 17, 2017 became vested on May 16, 2018 and shares were delivered to reporting person on such vest date. Read SEC document |
| May 16, 2018 Filed May 21, 2018 21:14 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 3,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-18-000010 · primary_doc.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 20, 2017 Filed Jul 14, 2017 22:34 UTC | OTONOMY, INC. OTIC · Entity 116495 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $16.05 | $0.00 |
DisclosureSEC source: 0001209191-17-045256 · doc4.xml · derivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-20 F1 · derivative.exercise_date: The shares subject to the option vest in full on the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| May 25, 2017 Filed May 30, 2017 18:23 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | GrantNonstatutory Stock Option (right to buy) · Derivative | 6,500 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001209191-17-036240 · doc4.xml · derivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock, $.01 par value · 6,500 shares Expires 2027-05-24 F1 · derivative.exercise_date: The date in this field is approximate. These options are exercisable at the date of the next annual meeting of stockholders. The date of the meeting has not been set, but is expected to occur in May 2018. Read SEC document |
| May 22, 2017 Filed Jun 8, 2017 22:31 UTC | NEUROCRINE BIOSCIENCES INC NBIX · Entity 2655 | GrantStock Option · Derivative | 15,000 | $0.00 Strike: $53.64 | $0.00 |
DisclosureSEC source: 0001209191-17-038631 · doc4.xml · derivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-05-22 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 22, 2017. Read SEC document |
| May 17, 2017 Filed May 18, 2017 23:51 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 3,115 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-17-000013 · primary_doc.xml · derivative · entry 3 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,115 Underlying: Common Stock · 3,115 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock F3 · derivative.exercise_date: 100% of the restricted stock unit will become vested upon the earlier of (1) one year after the date of grant or (2) the date of issuer's annual meeting of stockholders to be held in 2018. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit will become vested upon the earlier of (1) one year after the date of grant or (2) the date of issuer's annual meeting of stockholders to be held in 2018. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 17, 2017 Filed May 18, 2017 23:51 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-17-000013 · primary_doc.xml · derivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 18, 2016 became vested on May 17, 2017 and shares were delivered to reporting person on May 17, 2017. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 18, 2016 became vested on May 17, 2017 and shares were delivered to reporting person on May 17, 2017. Read SEC document |
| May 17, 2017 Filed May 18, 2017 23:51 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-17-000013 · primary_doc.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2010 Filed Apr 30, 2010 22:56 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,401 | $58.18 | $81,510.18 |
DisclosureSEC source: 0001127602-10-012676 · form4.xml · nonDerivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,488 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/29/2011; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/28/2011; and 12,000 RSUs which vest in four equal installments of 3,000 each commencing 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 28, 2010 Filed Apr 30, 2010 22:56 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,401 | $57.84 | $81,033.84 |
DisclosureSEC source: 0001127602-10-012676 · form4.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,889 Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 19:31 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 84,000 | $58.43 Strike: $58.43 | $4,908,120.00 |
DisclosureSEC source: 0001127602-10-012256 · form4.xml · derivative · entry 3 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2020-04-26 F4 · derivative.exercise_date: These options are exercisable in four equal annual installments of 25% each commencing 04/26/2011. Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 19:31 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012256 · form4.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,290 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Company's 2009 Equity Incentive Plan and vest in four equal annual installments of 25% each commencing April 26, 2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; 12,000 RSUs which vest in four equal annual installments of 3,000 each commencing 4/28/2010; and 12,000 RSUs which vest in four equal annual installments of 3,000 each commencing 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 12, 2010 Filed Mar 16, 2010 19:15 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 5,753 | $57.49 | $330,739.97 |
DisclosureSEC source: 0001127602-10-008776 · form4.xml · nonDerivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,290 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; and 12,000 RSUs which vests in four equal annual installments of 3,000 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| March 12, 2010 Filed Mar 16, 2010 19:15 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 12,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-008776 · form4.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,043 Read SEC document |
| June 09, 2009 Filed Jun 10, 2009 19:28 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 21,000 | $0.00 Strike: $42.13 | $0.00 |
DisclosureSEC source: 0001127602-09-013737 · form4.xml · derivative · entry 5 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,000 Underlying: Common Stock · 21,000 shares Expires 2015-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is exercisable in four equal annual installments of 25% each commencing April 29, 2009. Read SEC document |
| June 09, 2009 Filed Jun 10, 2009 19:28 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 900 | $50.98 | $45,882.00 |
DisclosureSEC source: 0001127602-09-013737 · form4.xml · nonDerivative · entry 3 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,719 F1 · security: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; and 12,000 RSUs which vests in four equal annual installments of 3,000 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| June 09, 2009 Filed Jun 10, 2009 19:28 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 20,100 | $51.08 | $1,026,681.87 |
DisclosureSEC source: 0001127602-09-013737 · form4.xml · nonDerivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,619 F1 · security: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; and 12,000 RSUs which vests in four equal annual installments of 3,000 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| June 09, 2009 Filed Jun 10, 2009 19:28 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 21,000 | $42.13 | $884,730.00 |
DisclosureSEC source: 0001127602-09-013737 · form4.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; and 12,000 RSUs which vests in four equal annual installments of 3,000 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| May 08, 2009 Filed May 8, 2009 21:08 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 8,788 | $47.63 | $418,572.44 |
DisclosureSEC source: 0001127602-09-011019 · form4.xml · nonDerivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,346 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; and 12,000 RSUs which vests in four equal annual installments of 3,000 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| May 07, 2009 Filed May 8, 2009 21:08 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 19,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-011019 · form4.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,134 Read SEC document |
| April 29, 2009 Filed May 1, 2009 22:52 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,373 | $50.44 | $69,254.12 |
DisclosureSEC source: 0001127602-09-010337 · form4.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,927 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; and 12,000 RSUs which vests in four equal annual installments of 3,000 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| April 28, 2009 Filed Apr 29, 2009 22:31 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 84,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-09-009987 · form4.xml · derivative · entry 4 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2016-04-28 F3 · derivative.exercise_date: These shares are exercisable in four equal annual installments of 25% each commencing 04/28/2010. Read SEC document |
| April 28, 2009 Filed Apr 29, 2009 22:31 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-009987 · form4.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Company's Amended and Restated 1991 Equity Incentive Plan (the "1991 Plan"). RSUs vest in four equal annual installments of 25% each commence April 28, 2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| October 24, 2008 Filed Oct 28, 2008 17:27 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 57,394 | $0.00 Strike: $38.36 | $0.00 |
DisclosureSEC source: 0001181431-08-058466 · rrd221649.xml · derivative · entry 3 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 57,394 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 24, 2008 Filed Oct 28, 2008 17:27 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 57,394 | $54.48 | $3,126,641.46 |
DisclosureSEC source: 0001181431-08-058466 · rrd221649.xml · nonDerivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,673 F1 · price: The sale price is an average safe price with a low of $54.10 per share and a high of $54.82 per share. A detailed list of each open market transaction at each seperate price is available upon request by the SEC staff, the issuer, or the security holder of the issuer. Read SEC document |
| October 24, 2008 Filed Oct 28, 2008 17:27 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 57,394 | $38.36 | $2,201,633.84 |
DisclosureSEC source: 0001181431-08-058466 · rrd221649.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2008 Filed May 14, 2008 21:15 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 26,891 | $41.86 | $1,125,657.26 |
DisclosureSEC source: 0001181431-08-031351 · rrd206656.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,673 Read SEC document |
| May 07, 2008 Filed May 9, 2008 21:28 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 60,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-030269 · rrd206040.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,564 Read SEC document |
| April 29, 2008 Filed May 1, 2008 00:07 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 84,000 | $42.13 Strike: $42.13 | $3,538,920.00 |
DisclosureSEC source: 0001181431-08-027703 · rrd204732.xml · derivative · entry 3 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2015-04-29 F3 · derivative.exercise_date: The option is exercisable in four equal annual installments of 25% each commencing April 29, 2009. Read SEC document |
| April 29, 2008 Filed May 1, 2008 00:07 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-027703 · rrd204732.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,906 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest in four equal annual installments of 25% each commencing on April 29, 2009. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deffered by the executive officer. Read SEC document |
| December 10, 2007 Filed Dec 12, 2007 00:47 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,609 | $38.36 | $100,081.24 |
DisclosureSEC source: 0001181431-07-074798 · rrd181800.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2007 Filed Dec 12, 2007 00:47 UTC | AMGEN INC AMGN · Entity 2832 | PurchaseCommon Stock | 2,025.425 | $69.97 | $141,718.99 |
DisclosureSEC source: 0001181431-07-074798 · rrd181800.xml · nonDerivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 2,025.425 F1 · balance_after: These are units acquired under the Company's 401(k) Plan and represent interests in the Company stock fund as of December 7, 2007. Read SEC document |
| May 11, 2007 Filed May 15, 2007 18:55 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 27,401 | $54.25 | $1,486,504.25 |
DisclosureSEC source: 0001181431-07-032476 · rrd158588.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,297 Read SEC document |
| May 08, 2007 Filed May 9, 2007 20:36 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 62,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-07-031044 · rrd156492.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,698 Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 21:32 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 63,402 | $62.55 Strike: $62.55 | $3,965,795.10 |
DisclosureSEC source: 0001181431-07-028130 · rrd156044.xml · derivative · entry 3 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,402 Underlying: Common Stock · 63,402 shares Expires 2014-04-26 F1 · derivative.exercise_date: This option is exercisable as follows: 16,250 shares on April 26, 2008; 16,250 shares on April 26, 2009; 16,250 shares on April 26, 2010; and 14,652 shares on April 26, 2011. Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 21:32 UTC | AMGEN INC AMGN · Entity 2832 | GrantISO (Right to Buy) · Derivative | 1,598 | $62.55 Strike: $62.55 | $99,954.90 |
DisclosureSEC source: 0001181431-07-028130 · rrd156044.xml · derivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,598 Underlying: Common Stock · 1,598 shares Expires 2014-04-26 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.